Increased mitochondrial thioredoxin 2 potentiates N-ethylmaleimide-induced cytotoxicity

Chemical Research in Toxicology

Volumn 21, Issue 6, 2008, Pages 1205-1210

  Chen, Yan ^a   Go, Young Mi ^b   Pohl, Jan ^b   Reed, Matthew ^b   Cai, Jiyang ^a   Jones, Dean P ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; DITHIOL DERIVATIVE; N ETHYLMALEIMIDE; PEROXIREDOXIN; PEROXIREDOXIN 3; THIOL; THIOREDOXIN; THIOREDOXIN 2;

ALKYLATION; ARTICLE; CELL LINE; CHEMICAL INTERACTION; CONTROLLED STUDY; COVALENT BOND; CYTOTOXICITY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MITOCHONDRIAL RESPIRATION; OXIDATION REDUCTION REACTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; WESTERN BLOTTING;

CELL LINE, TUMOR; ETHYLMALEIMIDE; GENE EXPRESSION REGULATION; HUMANS; MITOCHONDRIA; MUTATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; THIOREDOXINS;

EID: 47049098175     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx800012p     Document Type: Article

References (39)

1. Clavreul, N., Adachi, T., Pimental, D. R., Ido, Y., Schoneich, C., and Cohen, R. A. (2006) S-glutathiolation by peroxynitrite of p21ras at cysteine-118 mediates its direct activation and downstream signaling in endothelial cells. FASEB J. 20, 518-520.
2. Humphries, K. M., Deal, M. S., and Taylor, S. S. (2005) Enhanced dephosphorylation of cAMP-dependent protein kinase by oxidation and thiol modification. J. Biol. Chem. 280, 2750-2758.
3. Bhanoori, M., Yellaturu, C. R., Ghosh, S. K., Hassid, A., Jennings, L. K., and Rao, G. N. (2003) Thiol alkylation inhibits the mitogenic effects of platelet-derived growth factor and renders it proapoptotic via activation of STATs and p53 and induction of expression of caspasel and p21(waf1/cip1). Oncogene 22, 117-130.
4. Yellaturu, C. R., Bhanoori, M., Neeli, I., and Rao, G. N. (2002) N-Ethylmaleimide inhibits platelet-derived growth factor BB-stimulated Akt phosphorylation via activation of protein phosphatase 2A. J. Biol. Chem. 277, 40148-40155.
5. Jones, D. P. (2006) Redefining oxidative stress. Antioxid. Redox Signaling 8, 1865-1879.
6. Arner, E. S., and Holmgren, A. (2000) Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267, 6102-6109.
7. Powis, G., and Montfort, W. R. (2001) Properties and biological activities of thioredoxins. Annu. Rev. Pharmacol. Toxicol. 41, 261-295.
8. Nonn, L., Williams, R. R., Erickson, R. P., and Powis, G. (2003) The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol. Cell. Biol. 23, 916-922.
9. Tanaka, T., Hosoi, F., Yamaguchi-Iwai, Y., Nakamura, H., Masutani, H., Ueda, S., Nishiyama, A., Takeda, S., Wada, H., Spyrou, G., and Yodoi, J. (2002) Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J. 21, 1695-1703.
10. Chen, Y., Cai, J., Murphy, T. J., and Jones, D. P. (2002) Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells. J. Biol. Chem. 277, 33242-33248.
11. Damdimopoulos, A. E., Miranda-Vizuete, A., Pelto-Huikko, M., Gustafsson, J. A., and Spyrou, G. (2002) Human mitochondrial thioredoxin. Involvement in mitochondrial membrane potential and cell death. J. Biol. Chem. 277, 33249-33257.
12. Nonn, L., Berggren, M., and Powis, G. (2003) Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis. Mol. Cancer Res. 1, 682-689.
13. Chen, Y., Yu, M., Jones, D. P., Greenamyre, J. T., and Cai, J. (2006) Protection against oxidant-induced apoptosis by mitochondrial thioredoxin in SH-SY5Y neuroblastoma cells. Toxicol. Appl. Pharmacol. 216, 256-262.
14. Chen, Y., Cai, J., and Jones, D. P. (2006) Mitochondrial thioredoxin in regulation of oxidant-induced cell death. FEBS Lett. 580, 6596-6602.
15. Hansen, J. M., Zhang, H., and Jones, D. P. (2006) Differential oxidation of thioredoxin-1, thioredoxin-2, and glutathione by metal ions. Free Radical Biol. Med. 40, 138-145.
16. Hansen, J. M., Zhang, H., and Jones, D. P. (2006) Mitochondrial thioredoxin-2 has a key role in determining tumor necrosis factor-alpha-induced reactive oxygen species generation, NF-kappaB activation, and apoptosis. Toxicol. Sci. 91, 643-650.
17. Ha, K. N., Chen, Y., Cai, J., and Sternberg, P., Jr. (2006) Increased glutathione synthesis through an ARE-Nrf2-dependent pathway by zinc in the RPE: implication for protection against oxidative stress. Invest. Ophthalmol. Visual Sci. 47, 2709-2715.
18. Fang, J., and Holmgren, A. (2006) Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo. J. Am. Chem. Soc. 128, 1879-1885.
19. Go, Y. M., Halvey, P. J., Hansen, J. M., Reed, M., Pohl, J., and Jones, D. P. (2007) Reactive aldehyde modification of thioredoxin-1 activates early steps of inflammation and cell adhesion. Am. J. Pathol. 171, 1670-1681.
20. Yang, X., Wu, X., Choi, Y. E., Kern, J. C., and Kehrer, J. P. (2004) Effect of acrolein and glutathione depleting agents on thioredoxin. Toxicology 204, 209-218.
21. Bragadin, M., Scutari, G., Folda, A., Bindoli, A., and Rigobello, M. P. (2004) Effect of metal complexes on thioredoxin reductase and the regulation of mitochondrial permeability conditions. Ann. N. Y. Acad. Sci. 1030, 348-354.
22. Meyer, M., Jensen, O. N., Barofsky, E., Barofsky, D. F., and Reed, D. J. (1994) Thioredoxin alkylation by a dihaloethane-glutathione conjugate. Chem. Res. Toxicol. 7, 659-665.
23. Liebler, D. C. (2002) Proteomic approaches to characterize protein modifications: new tools to study the effects of environmental exposures. Environ. Health Perspect. 110 (Suppl. 1), 3-9.
24. Dennehy, M. K., Richards, K. A., Wernke, G. R., Shyr, Y., and Liebler, D. C. (2006) Cytosolic and nuclear protein targets of thiol-reactive electrophiles. Chem. Res. Toxicol. 19, 20-29.
25. Zhang, R., Al-Lamki, R., Bai, L., Streb, J. W., Miano, J. M., Bradley, J., and Min, W. (2004) Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner. Circ. Res. 94, 1483-1491.
26. Zhang, H., Go, Y. M., and Jones, D. P. (2007) Mitochondrial thioredoxin-2/peroxiredoxin-3 system functions in parallel with mitochondrial GSH system in protection against oxidative stress. Arch. Biochem. Biophys. 465, 119-126.
27. Casagrande, S., Bonetto, V., Fratelli, M., Gianazza, E., Eberini, I., Massignan, T., Salmona, M., Chang, G., Holmgren, A., and Ghezzi, P. (2002) Glutathionylation of human thioredoxin: a possible crosstalk between the glutathione and thioredoxin systems. Proc. Natl. Acad. Sci. U.S.A. 99, 9745-9749.
28. Haendeler, J., Hoffmann, J., Tischler, V., Berk, B. C., Zeiher, A. M., and Dimmeler, S. (2002) Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nat. Cell Biol. 4, 743-749.
29. Watson, W. H., Pohl, J., Montfort, W. R., Stuchlik, O., Reed, M. S., Powis, G., and Jones, D. P. (2003) Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motif. J. Biol. Chem. 278, 33408-33415.
30. Shibata, T., Yamada, T., Ishii, T., Kumazawa, S., Nakamura, H., Masutani, H., Yodoi, J., and Uchida, K. (2003) Thioredoxin as a molecular target of cyclopentenone prostaglandins. J. Biol. Chem. 278, 26046-26054.
31. Kallis, G. B., and Holmgren, A. (1980) Differential reactivity of the functional sulfhydryl groups of cysteine-32 and cysteine-35 present in the reduced form of thioredoxin from Escherichia coli. J. Biol. Chem. 255, 10261-10265.
32. Shao, L., Diccianni, M. B., Tanaka, T., Gribi, R., Yu, A. L., Pullen, J. D., Camitta, B. M., and Yu, J. (2001) Thioredoxin expression in primary T-cell acute lymphoblastic leukemia and its therapeutic implication. Cancer Res. 61, 7333-7338.
33. Raffel, J., Bhattacharyya, A. K., Gallegos, A., Cui, H., Einspahr, J. G., Alberts, D. S., and Powis, G. (2003) Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival. J. Lab. Clin. Med. 142, 46-51.
34. Grogan, T. M., Fenoglio-Prieser, C., Zeheb, R., Bellamy, W., Frutiger, Y., Vela, E., Stemmerman, G., Macdonald, J., Richter, L., Gallegos, A., and Powis, G. (2000) Thioredoxin, a putative oncogene product, is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival. Hum. Pathol. 31, 475-481.
35. Engman, L., Al-Maharik, N., McNaughton, M., Birmingham, A., and Powis, G. (2003) Thioredoxin reductase and cancer cell growth inhibition by organotellurium antioxidants. Anticancer Drugs 14, 153-161.
36. Ramanathan, R. K., Kirkpatrick, D. L., Belani, C. P., Friedland, D., Green, S. B., Chow, H. H., Cordova, C. A., Stratton, S. P., Shadow, E. R., Baker, A., and Dragovich, T. (2007) A Phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors. Clin. Cancer Res. 13, 2109-2114.
37. Hashemy, S. I., Ungerstedt, J. S., Zahedi Avval, F., and Holmgren, A. (2006) Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase. J. Biol. Chem. 281, 10691-10697.
38. Kirkpatrick, D. L., Kuperus, M., Dowdeswell, M., Potier, N., Donald, L. J., Kunkel, M., Berggren, M., Angulo, M., and Powis, G. (1998) Mechanisms of inhibition of the thioredoxin growth factor system by antitumor 2-imidazolyl disulfides. Biochem. Pharmacol. 55, 987-994.
39. Dvorakova, K., Payne, C. M., Tome, M. E., Briehl, M. M., Vasquez, M. A., Waltmire, C. N., Coon, A., and Dorr, R. T. (2002) Molecular and cellular characterization of imexon-resistant RPMI8226/I myeloma cells. Mol. Cancer Ther. 1, 185-195.